Logo image of HR

HEALTHCARE REALTY TRUST INC (HR) Stock Fundamental Analysis

NYSE:HR - New York Stock Exchange, Inc. - US42226K1051 - REIT

16.91  +0.43 (+2.61%)

After market: 16.91 0 (0%)

Fundamental Rating

2

Overall HR gets a fundamental rating of 2 out of 10. We evaluated HR against 129 industry peers in the Diversified REITs industry. Both the profitability and financial health of HR have multiple concerns. HR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year HR has reported negative net income.
In the past year HR had a positive cash flow from operations.
Of the past 5 years HR 4 years were profitable.
Each year in the past 5 years HR had a positive operating cash flow.
HR Yearly Net Income VS EBIT VS OCF VS FCFHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500M -1B -1.5B -2B

1.2 Ratios

The Return On Assets of HR (-2.23%) is worse than 78.57% of its industry peers.
HR's Return On Equity of -4.13% is on the low side compared to the rest of the industry. HR is outperformed by 72.22% of its industry peers.
HR has a Return On Invested Capital of 0.35%. This is amonst the worse of the industry: HR underperforms 88.89% of its industry peers.
HR had an Average Return On Invested Capital over the past 3 years of 1.01%. This is below the industry average of 3.11%.
Industry RankSector Rank
ROA -2.23%
ROE -4.13%
ROIC 0.35%
ROA(3y)-0.18%
ROA(5y)0.14%
ROE(3y)-0.2%
ROE(5y)0.39%
ROIC(3y)1.01%
ROIC(5y)1.4%
HR Yearly ROA, ROE, ROICHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2 -2 4 -4 6

1.3 Margins

The Operating Margin of HR (4.04%) is worse than 88.89% of its industry peers.
HR's Operating Margin has declined in the last couple of years.
HR's Gross Margin of 62.76% is on the low side compared to the rest of the industry. HR is outperformed by 67.46% of its industry peers.
In the last couple of years the Gross Margin of HR has declined.
Industry RankSector Rank
OM 4.04%
PM (TTM) N/A
GM 62.76%
OM growth 3Y-43.5%
OM growth 5Y-29.46%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.25%
GM growth 5Y-1.68%
HR Yearly Profit, Operating, Gross MarginsHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

HR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for HR remains at a similar level compared to 1 year ago.
HR has more shares outstanding than it did 5 years ago.
The debt/assets ratio for HR is higher compared to a year ago.
HR Yearly Shares OutstandingHR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M
HR Yearly Total Debt VS Total AssetsHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B 10B

2.2 Solvency

HR has an Altman-Z score of 0.41. This is a bad value and indicates that HR is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.41, HR is doing worse than 63.49% of the companies in the same industry.
HR has a debt to FCF ratio of 28.39. This is a negative value and a sign of low solvency as HR would need 28.39 years to pay back of all of its debts.
HR has a better Debt to FCF ratio (28.39) than 64.29% of its industry peers.
A Debt/Equity ratio of 0.74 indicates that HR is somewhat dependend on debt financing.
HR's Debt to Equity ratio of 0.74 is fine compared to the rest of the industry. HR outperforms 74.60% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 28.39
Altman-Z 0.41
ROIC/WACC0.05
WACC6.45%
HR Yearly LT Debt VS Equity VS FCFHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B -2B 4B 6B

2.3 Liquidity

A Current Ratio of 0.47 indicates that HR may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.47, HR is doing worse than 90.48% of the companies in the same industry.
HR has a Quick Ratio of 0.47. This is a bad value and indicates that HR is not financially healthy enough and could expect problems in meeting its short term obligations.
HR has a worse Quick ratio (0.47) than 86.51% of its industry peers.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.47
HR Yearly Current Assets VS Current LiabilitesHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

More info and screens

3

3. Growth

3.1 Past

HR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -27.78%.
The Revenue has grown by 44.09% in the past year. This is a very strong growth!
The Revenue has been growing by 14.05% on average over the past years. This is quite good.
EPS 1Y (TTM)-27.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-44.44%
Revenue 1Y (TTM)44.09%
Revenue growth 3Y22.06%
Revenue growth 5Y14.05%
Sales Q2Q%-7.84%

3.2 Future

HR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.52% yearly.
The Revenue is expected to decrease by -1.23% on average over the next years.
EPS Next Y-110.87%
EPS Next 2Y20.63%
EPS Next 3Y13.52%
EPS Next 5YN/A
Revenue Next Year-6.33%
Revenue Next 2Y-3.52%
Revenue Next 3Y-1.23%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HR Yearly Revenue VS EstimatesHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
HR Yearly EPS VS EstimatesHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 -1 -1.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HR Price Earnings VS Forward Price EarningsHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HR is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, HR is valued a bit cheaper than the industry average as 61.11% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 33.56
EV/EBITDA 14.06
HR Per share dataHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

A more expensive valuation may be justified as HR's earnings are expected to grow with 13.52% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.63%
EPS Next 3Y13.52%

More info and screens

5

5. Dividend

5.1 Amount

HR has a Yearly Dividend Yield of 7.52%, which is a nice return.
HR's Dividend Yield is rather good when compared to the industry average which is at 18.51. HR pays more dividend than 80.16% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.28, HR pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.52%

5.2 History

The dividend of HR decreases each year by -14.26%.
HR has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of HR decreased recently.
Dividend Growth(5Y)-14.26%
Div Incr Years0
Div Non Decr Years1
HR Yearly Dividends per shareHR Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6

5.3 Sustainability

HR has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-167.7%
EPS Next 2Y20.63%
EPS Next 3Y13.52%
HR Yearly Income VS Free CF VS DividendHR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B -1B -2B

More info and screens

HEALTHCARE REALTY TRUST INC

NYSE:HR (1/21/2025, 8:05:58 PM)

After market: 16.91 0 (0%)

16.91

+0.43 (+2.61%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-30 2024-10-30/bmo
Earnings (Next)02-14 2025-02-14/amc
Inst Owners107.26%
Inst Owner Change-0.2%
Ins Owners0.52%
Ins Owner Change1.2%
Market Cap5.99B
Analysts73.68
Price Target18.61 (10.05%)
Short Float %3.67%
Short Ratio3.66
Dividend
Industry RankSector Rank
Dividend Yield 7.52%
Yearly Dividend0.79
Dividend Growth(5Y)-14.26%
DP-167.7%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-14.33%
Min EPS beat(2)-34.43%
Max EPS beat(2)5.77%
EPS beat(4)1
Avg EPS beat(4)-49.93%
Min EPS beat(4)-101.53%
Max EPS beat(4)5.77%
EPS beat(8)3
Avg EPS beat(8)104.68%
EPS beat(12)6
Avg EPS beat(12)72.79%
EPS beat(16)9
Avg EPS beat(16)50.09%
Revenue beat(2)0
Avg Revenue beat(2)-2.64%
Min Revenue beat(2)-4.55%
Max Revenue beat(2)-0.72%
Revenue beat(4)0
Avg Revenue beat(4)-2.01%
Min Revenue beat(4)-4.55%
Max Revenue beat(4)-0.72%
Revenue beat(8)1
Avg Revenue beat(8)6.47%
Revenue beat(12)1
Avg Revenue beat(12)3.4%
Revenue beat(16)1
Avg Revenue beat(16)2.05%
PT rev (1m)0%
PT rev (3m)-0.34%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-22.51%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-0.69%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.46
P/FCF 33.56
P/OCF 11.99
P/B 0.88
P/tB 0.92
EV/EBITDA 14.06
EPS(TTM)-0.92
EYN/A
EPS(NY)-0.4
Fwd EYN/A
FCF(TTM)0.5
FCFY2.98%
OCF(TTM)1.41
OCFY8.34%
SpS3.79
BVpS19.25
TBVpS18.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.23%
ROE -4.13%
ROCE 0.44%
ROIC 0.35%
ROICexc 0.35%
ROICexgc 0.36%
OM 4.04%
PM (TTM) N/A
GM 62.76%
FCFM 13.29%
ROA(3y)-0.18%
ROA(5y)0.14%
ROE(3y)-0.2%
ROE(5y)0.39%
ROIC(3y)1.01%
ROIC(5y)1.4%
ROICexc(3y)1.01%
ROICexc(5y)1.42%
ROICexgc(3y)1.03%
ROICexgc(5y)1.43%
ROCE(3y)1.27%
ROCE(5y)1.77%
ROICexcg growth 3Y-44.53%
ROICexcg growth 5Y-30.41%
ROICexc growth 3Y-44.93%
ROICexc growth 5Y-30.59%
OM growth 3Y-43.5%
OM growth 5Y-29.46%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.25%
GM growth 5Y-1.68%
F-Score5
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 28.39
Debt/EBITDA 6.46
Cap/Depr 43.96%
Cap/Sales 23.91%
Interest Coverage 0.25
Cash Conversion 63.68%
Profit Quality N/A
Current Ratio 0.47
Quick Ratio 0.47
Altman-Z 0.41
F-Score5
WACC6.45%
ROIC/WACC0.05
Cap/Depr(3y)109.07%
Cap/Depr(5y)137.16%
Cap/Sales(3y)48.01%
Cap/Sales(5y)57.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-44.44%
EPS Next Y-110.87%
EPS Next 2Y20.63%
EPS Next 3Y13.52%
EPS Next 5YN/A
Revenue 1Y (TTM)44.09%
Revenue growth 3Y22.06%
Revenue growth 5Y14.05%
Sales Q2Q%-7.84%
Revenue Next Year-6.33%
Revenue Next 2Y-3.52%
Revenue Next 3Y-1.23%
Revenue Next 5YN/A
EBIT growth 1Y-34.44%
EBIT growth 3Y-31.04%
EBIT growth 5Y-19.55%
EBIT Next Year1189.02%
EBIT Next 3Y138.19%
EBIT Next 5Y93.05%
FCF growth 1Y153.92%
FCF growth 3Y51.95%
FCF growth 5Y-3%
OCF growth 1Y83.29%
OCF growth 3Y8.81%
OCF growth 5Y8.18%